Bolsonaro's clash with Sao Paulo governor over the Chinese vaccine tainted with politics

Brazil’s national health regulator allowed clinical trials of a Chinese-developed Covid-19 vaccine to resume on Wednesday, two days after suspending them in what critics called a decision tainted by politics. The regulatory agency, Anvisa, said it had now received more details on the nature of the adverse “incident” that led it to halt final stage trials of the CoronaVac vaccine, and had “sufficient information to allow vaccination to resume.” Public health officials had said the incident that led to the suspension – a volunteer recipient’s death, which police are investigating as a suicide – had no connection with the vaccine.